Last: | $40.255 |
---|---|
Change Percent: | 0.66% |
Open: | $40.11 |
Close: | $39.99 |
High: | $40.53 |
Low: | $39.865 |
Volume: | 45,799 |
Last Trade Date Time: | 07/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$40.255 | $40.11 | $39.99 | $40.53 | $39.865 | 45,799 | 07-23-2024 |
$39.99 | $40.05 | $39.99 | $40.24 | $38.6 | 981,522 | 07-22-2024 |
$40 | $40.57 | $40 | $40.81 | $39.86 | 449,594 | 07-19-2024 |
$40.32 | $40.7 | $40.32 | $41.19 | $39.985 | 924,124 | 07-18-2024 |
$40.82 | $40.72 | $40.82 | $41.3021 | $40.41 | 578,004 | 07-17-2024 |
$41.26 | $40.28 | $41.26 | $41.39 | $39.511 | 603,473 | 07-16-2024 |
$40.22 | $40.57 | $40.22 | $40.88 | $40.09 | 606,143 | 07-15-2024 |
$40.23 | $40.53 | $40.23 | $41.18 | $40.21 | 435,544 | 07-12-2024 |
$40.15 | $40.43 | $40.15 | $41.24 | $39.68 | 1,088,659 | 07-11-2024 |
$39.18 | $40.52 | $39.18 | $40.655 | $38.28 | 1,281,653 | 07-10-2024 |
$39.72 | $41.09 | $39.72 | $41.09 | $39.3 | 1,254,295 | 07-09-2024 |
$41.06 | $41.88 | $41.06 | $41.88 | $40.75 | 510,733 | 07-08-2024 |
$41.95 | $41.5 | $41.95 | $42.5 | $41.22 | 446,974 | 07-05-2024 |
$41.96 | $42.77 | $41.96 | $42.98 | $41.82 | 254,621 | 07-04-2024 |
$41.96 | $42.77 | $41.96 | $42.98 | $41.82 | 254,621 | 07-03-2024 |
$42.72 | $43.03 | $42.72 | $43.72 | $42.29 | 550,094 | 07-02-2024 |
$43.17 | $43.23 | $43.17 | $43.445 | $42.49 | 733,084 | 07-01-2024 |
$43.23 | $43.16 | $43.23 | $44.28 | $42.99 | 2,548,490 | 06-28-2024 |
$42.7 | $40.59 | $42.7 | $42.9 | $40.4 | 1,363,614 | 06-27-2024 |
$40.55 | $37.75 | $40.55 | $41.88 | $37.19 | 3,996,488 | 06-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...
2024-07-09 22:15:01 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for RPD on July 9, 2024 09:06PM ET. The previous analyst recommendation was Equal-Weight. RPD was trading at $39.72 at issue of the analyst recommendation. The overall analyst consensus : BU...